Observational study of patients treated with a matched unrelated donor

  • Research type

    Research Study

  • Full title

    A Prospective observational study of paediatric patients affected by haematological disorders treated with matched unrelated donor stem cell transplant

  • IRAS ID

    230731

  • Contact name

    Waseem Qasim

  • Contact email

    w.qasim@ucl.ac.uk

  • Sponsor organisation

    Bellicum Pharmaceuticals, Inc.

  • Duration of Study in the UK

    0 years, 9 months, 1 days

  • Research summary

    This is a prospective observational study of Paediatric patients affected by haematological disorders who do not have a matched related donor (optimal standard of care) but are treated with matched unrelated donor (MUD) stem cell transplantation (9/10 or 10/10 HLA match).
    Patients will be enrolled regardless of disease, malignant diseases include high-risk ALL in 1st CR, ALL in 2nd or subsequent CR, high-risk AML in 1st CR, AML in 2nd CR, myelodysplastic syndromes. Also non-malignant diseases which include primary immune deficiencies, osteopetrosis, inherited bone marrow failure disorders selected cases of erythroid disorders such as β0 β0 thalassemia major, sickle cell disease, Diamond-Blackfan anaemia congenital/hereditary cytopenia, including Fanconi Anemia before any clonal malignant evolution (MDS, AML).
    After informed consent, the patients will be screened against the inclusion/exclusion criteria, and if meeting the inclusion/exclusion criteria, the subject will be enrolled and data collected.
    Up to 30 patients from the ages of 0-18 years will be enrolled onto the study. The minimum study data collection for each patient will be for 180 days post-transplant. The data collected for these patients will be used to serve as a comparison to the BP-004 protocol in which paediatric patients with haematologic disorders who do not have a matched related, or matched unrelated donor undergo haploidentical transplantation HSCT followed by BPX-501 T cell addback.

  • REC name

    London - South East Research Ethics Committee

  • REC reference

    17/LO/1571

  • Date of REC Opinion

    18 Sep 2017

  • REC opinion

    Favourable Opinion